clavicular ghk cu GHK-Cu (100mg) 6ml Vial your son has been watching

FDA Provided Clarity on GHK-Cu On May 14, 2026, the FDA restored non-injectable GHK-Cu to Category 1 of the 503A bulk drug substances list, confirming that the earlier withdrawal applied only to injectable routes of administration

Systemic effects less commonly include mild dizziness or lightheadedness (may be copper-related), temporary nausea or headache (typically resolves within hours), mild fatigue (rare, reported with higher doses), and transient flu-like symptoms (very rare, may relate to systemic inflammatory response)

Practical decision framing in the research-use community: if the research interest is structural repair, soft-tissue work, or skin remodeling alone, GLOW covers those bases

Closing: Why the Stack Matters More Than the Individual Parts GHK-Cu and SkinPen microneedling are both effective tools used independently